Quarterly Activity Report for 31 December 2020 — Appendix 4C

Quarterly Activity Report for 31 December 2020 — Appendix 4C

Imagion Biosystems today released its Appendix 4C Quarterly Cashflow report and update on Company activities for the quarter ending 31 December 2020 (Q4 FY2020).

Q4 Highlights:

  • Raised $5.6 million (net of costs) in oversubscribed placement, with funds to be used on product development and manufacturing scale-up
  • MagSenseTM HER2 breast cancer Phase I study open for enrolment, with Monash Health established as first clinical site

Read the Quarterly Activity Report for December 31, 2020.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.